Summary
The majority of toxic shock syndrome cases are caused by a specific toxin, toxic shock syndrome toxin 1, produced by some strains of Staphylococcus aureus. These organisms are common inhabitants of hospitals and are difficult to control because of development of resistance to antibiotics. A number of cases of toxic shock syndrome have resulted from staphylococcal infected incisions in surgery patients following many different types of surgical procedures, including nasal operations. In some cases the staphylococcal strain isolated from the infection was identical to one isolated from the surgeon.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barbour SD, Shales DM, Guertin SR. Toxic-shock syndrome associated with nasal packing: analogy to tampon-associated illness. Pediatrics 73: 163–163, 1984.
Bartlett P, Reingold AL, Graham DR, Dan BB, Selinger DS, Tank GW, Wichterman KA. Toxic shock syndrome associated with surgical wound infections. J Am Med Assoc 247: 1448–1450, 1982.
Bergdoll MS, Schlievert PM. Toxic shock syndrome toxin. Lancet ii: 691.
Breda SD, Jacobs JB, Lebowitz AS, Tiemo PM. Toxic shock syndrome in nasal surgery: a physicochemical and microbiologie evaluation of Merocel® and Nu-Gauze® basal packing. Laryngoscope 97: 1388–1391, 1987.
Crass BA, Bergdoll MS. Toxin involvement in toxic shock syndrome. J Infect Dis 153: 918–926, 1986.
Crass BA, Bergdoll MS. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome. J Clin Microbiol 23: 1138–1139, 1986.
Davis JP, Chesney PJ, Wand PJ, LaVenture M.D Toxic-shock syndrome: epidemiological features, recurrence, risk factors, and prevention. N Eng J Med 303: 1429 1435, 1980.
Farber BF, Broome CV, Hopkins CC. Fulminant hospital-acquired toxic shock syndrome. Am J Med 77: 331–332.
Jacobson JA, Kasworm EM, Crass BA, Bergdoll MS. Nasal carriage of toxigenicStaphylococcus aureus and prevalence of serum antibody to toxic-shock-syndrome toxin 1 in Utah. J Infect Dis 153: 356–359, 1986.
Kreiswirth BN, Kravitz GR, Schlievert PM, Novick RP. Nosocomial transmission of a strain of Staphylococcus aureus causing toxic shock syndrome. Ann Intern Med 105: 704–707, 1986.
MacDonald KL, Osterholm MT, Hedberg CW, Schrock CG, Peterson GF, Jentzen JM, Leonard SA, Schlievert PM. Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. J Am Med Assoc 257: 1053–1058, 1987.
Milner LS, De Jager J, Thompson PD, Doehring RO. Toxic shock syndrome caused by staphylococcal enterotoxin B. A report of two cases in children. S African Med J 63: 822–824, 1983.
Moyer MA, Edwards LD, Bergdoll MS. Nosocomial toxic-shock syndrome in two patients after knee surgery. Am J Infect Control 11: 83–87, 1983.
Nahass RG, Goske DJ. Toxic shock syndrome associated with use of a nasal tampon. Am J Med 84: 629–631, 1988.
Ritz HL, Kirkland JJ, Bond GG, Warner EK, Petty GP. Association of high levels of serum antibody to staphylococcal toxic shock antigen with nasal carriage of toxic shock antigen-producing strains of Staphylococcus aureus. Infect Immun 43: 954–958, 1984.
Schlievert PM. Staphylococcal enterotoxin B and toxic shock syndrome toxin 1 are significantly associated with nonmenstrual toxic shock syndrome. Lancet is 1149, 1986.
Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, Anderson RL, Hill DL, Broome CV, Band JD, Fraser DW. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Eng J Med 303: 1436–1442, 1980.
Surgalla MJ, Dack GM. Enterotoxin produced by micrococci from cases of enteritis after antibiotic therapy. J Am Med Assoc 158: 649–650, 1955.
Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet ii: 1116–1118, 1978.
Vergeront JM, Stolz SJ, Crass BA, Nelson DB, Davis JP, Bergdoll MS. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis 148: 692–698, 1983.
Wagner R, Toback JM. Toxic shock syndrome following septoplasty using plastic septal splints. Laryngoscope 96: 609–610, 1986.
Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Eng J Med 260: 1303–1308, 1959.
Westenfelder G, Steinberg JP, Bergdoll MS. unpublished data, 1987.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag London Limited
About this chapter
Cite this chapter
Bergdoll, M.S. (1990). Toxic Shock Syndrome from Surgical Infections. In: Wadström, T., Eliasson, I., Holder, I., Ljungh, Å. (eds) Pathogenesis of Wound and Biomaterial-Associated Infections. Springer, London. https://doi.org/10.1007/978-1-4471-3454-1_15
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3454-1_15
Publisher Name: Springer, London
Print ISBN: 978-3-540-19596-2
Online ISBN: 978-1-4471-3454-1
eBook Packages: Springer Book Archive